BioMarin Pharmaceutical Inc. (BMRN) vs Encompass Health Corporation (EHC)
A side-by-side comparison of BioMarin Pharmaceutical Inc. and Encompass Health Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BMRN
BioMarin Pharmaceutical Inc.
$56.82HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
EHC
Encompass Health Corporation
$124.64HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — BMRN vs EHC
growth of $100 · dividends reinvested · last 10yBMRN -39.5% (-4.9%/yr)EHC +325.7% (+15.6%/yr)EHC compounded faster over this window
Log scale — wide-divergence pair
BMRN EHC
BMRN vs EHC: by the numbers
- •EHC is the larger company ($12.36B vs $10.98B market cap).
- •EHC trades at the lower trailing earnings multiple (20.30 vs 145.68 P/E), one valuation lens rather than an overall verdict.
- •EHC converts more revenue to profit (10.01% vs 2.14% net margin).
- •BMRN grew revenue faster over the past five years (12.19% vs 4.81% CAGR).
- •EHC pays a dividend (0.63% yield), while BMRN has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | BMRN | EHC |
|---|---|---|
| P/E ratio | 145.68 | 20.30 |
| Forward P/E | N/A | 20.39 |
| PEG ratio | N/A | 1.43 |
| P/S ratio | 3.22 | 1.99 |
| P/B ratio | 1.74 | 4.76 |
| EV / EBITDA | 33.57 | 10.32 |
| FCF yield | 6.67% | 3.34% |
Profitability
| Metric | BMRN | EHC |
|---|---|---|
| Gross margin | 75.55% | 95.71% |
| Operating margin | 16.56% | 18.00% |
| Net margin | 2.14% | 10.01% |
| ROE | 1.15% | 23.91% |
| ROIC | 1.40% | 13.42% |
Dividends
| Metric | BMRN | EHC |
|---|---|---|
| Dividend yield | N/A | 0.63% |
| Payout ratio | N/A | 12.38% |
Growth (annualized)
| Metric | BMRN | EHC |
|---|---|---|
| Revenue CAGR (5Y) | 12.19% | 4.81% |
| EPS CAGR (5Y) | -17.46% | 14.39% |
| FCF CAGR (5Y) | 33.84% | 0.28% |
| Total return CAGR (5Y) | -5.59% | 17.12% |
Frequently asked
- Which has the lower trailing P/E, BMRN or EHC?
- EHC has the lower trailing P/E: BMRN trades at 145.68 and EHC at 20.30. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, BMRN or EHC?
- Over the past five years, BMRN grew revenue faster — BMRN at a 12.19% CAGR versus EHC at 4.81%.
- Does BMRN or EHC pay a bigger dividend?
- EHC pays a dividend (0.63% yield), while BMRN has no payments in the available dividend history.
- Is BMRN or EHC more profitable?
- EHC runs the higher net margin — BMRN at 2.14% versus EHC at 10.01%.
- How have BMRN and EHC total returns compared?
- Over the past 10 years, BMRN delivered -4.98% and EHC delivered 15.79% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
BioMarin Pharmaceutical P/E ratioEncompass Health P/E ratioEncompass Health dividend yieldBioMarin Pharmaceutical ROEEncompass Health ROEBioMarin Pharmaceutical operating marginEncompass Health operating marginBioMarin Pharmaceutical revenue growthEncompass Health revenue growthBioMarin Pharmaceutical free cash flowEncompass Health free cash flow
BioMarin Pharmaceutical & Encompass Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.